1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp
XNAS: ABUS
Await Turnaround
Download real time
4.41 0.12 (2.80%)
35.28% Gain from 52W Low
786.2K
XNAS Volume

XNAS 30 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Arbutus Biopharma Corp is on 06 Aug 2026 for the purpose of Arbutus Biopharma Corp Second Quarter Earnings Results for 2026 See details

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 2 analysts

Arbutus Biopharma Corp has a share price target of US$ 5, revenue growth forecast of 1153.4%, and profit growth estimate of 553.9% for FY26, based on top 2 analyst calls.

Forecaster Screeners